3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Congenital Abnormalities
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumor, Pleural
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Melanoma
1
Malignant Tumor of Ill-defined Site
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Interventions
fludarabine phosphate
15
Cyclophosphamide
13
Whole-Body Irradiation
12
Peripheral Blood Stem Cell Transplantation
12
Tacrolimus
10
Etoposide
10
Rituximab
8
Mycophenolic Acid
8
Methotrexate
6
Melphalan
6
Cyclosporine
6
Busulfan
6
Antilymphocyte Serum
6
Vorinostat
4
Sirolimus
4
Prednisone
4
Lenalidomide
4
Immunohistochemistry
4
Gene Expression Profiling
4
Carboplatin
4
Vincristine
3
Microarray Analysis
3
Gemcitabine
3
Everolimus
3
Doxorubicin
3
Dexamethasone
3
Brentuximab Vedotin
3
Alemtuzumab
3
10-propargyl-10-deazaaminopterin
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoblastic Lymphadenopathy
×
Pharmacogenomic Testing
×
Clear all
No trials found.